pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 2
efpegerglucagon
efpegerglucagon [INN]
Hyperinsulinemia
Hanmi Pharmaceuticals Co Ltd
Phase 3
efruxifermin
efruxifermin
Metabolic Dysfunction-Associated Steatohepatitis (MASH or…
Akero Therapeutics Inc
Phase 3
efsudenermin alfa
efsudenermin alfa
X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
EspeRare Foundation
← prev
page 206 of 271
next →
Pain
89
Neurology
1
Phase 3
eftilagimod alfa
eftilagimod alfa [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$IMMP
IMMUTEP Ltd
Phase 3
efzimfotase alfa
efzimfotase alfa
Hypophosphatasia
Alexion Pharmaceuticals Inc
Phase 2
efzofitimod
efzofitimod [INN]
Interstitial Lung Diseases (Diffuse Parenchymal Lung Dise…
$ATYR
aTYR PHARMA INC
Phase 2
egalognastat
egalognastat [INN]
Progressive Supranuclear Palsy
Grupo Ferrer Internacional SA
Marketed
elacestrant hydrochloride
Orserdu (elacestrant hydrochloride)
Metastatic Breast Cancer
A. Menarini Industrie Farmaceutiche Riunite Srl
Marketed
eladocagene exuparvovec
Kebilidi (eladocagene exuparvovec)
Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency
$PTC
PTC INC.
Marketed
elafibranor
Iqirvo (elafibranor)
Primary Sclerosing Cholangitis
Ipsen SA
Marketed
elagolix sodium + estradiol + norethindrone + elagolix sodium
Oriahnn (elagolix sodium + estradiol + norethindrone + elagolix sodium)
Menorrhagia
$ABBV
AbbVie Inc.
Marketed
elapegademase
Revcovi (elapegademase-lvlr)
Adenosine Deaminase (ADA) Deficiency Related SCID
Leadiant Biosciences Inc
Marketed
elasomeran
Spikevax (elasomeran [INN])
Coronavirus Disease 2019 (COVID-19)
$MRNA
Moderna, Inc.
Phase 3
elebsiran
elebsiran
Hepatitis D
$VIR
Vir Biotechnology, Inc.
Phase 3
elebsiran + tobevibart
elebsiran + tobevibart
Hepatitis D
$VIR
Vir Biotechnology, Inc.
Phase 2
elecoglipron
elecoglipron
Type 2 Diabetes
$AZN
ASTRAZENECA PLC
Phase 3
elegrobart
elegrobart
Graves' Ophthalmopathy
Viridian Therapeutics Inc
Phase 3
elenestinib
elenestinib
Systemic Mastocytosis
Blueprint Medicines Corp
Preclinical
elesclomol
elesclomol
Endometrial Cancer
Edison Oncology Holding Corp
Marketed
eletriptan hydrobromide
Eletriptan Hydrobromide
Migraine
Beximco Pharmaceuticals USA Inc
Phase 2
elezanumab
elezanumab
Traumatic Spinal Cord Injury
$ABBV
AbbVie Inc.
Phase 3
elfucose
elfucose
Inherited Metabolic Disorders
AUG Therapeutics LLC
Phase 2
elifactant
elifactant
Neonatal Respiratory Distress Syndrome
Chiesi Farmaceutici SpA
Marketed
eliglustat tartrate
Eliglustat Tartrate
Gaucher Disease Type I
Aizant Drug Research Solutions Pvt Ltd
Marketed
elinzanetant
Lynkuet (elinzanetant)
Vasomotor Symptoms of Menopause (Hot Flashes)
Bayer USA LLC
Phase 2
elironrasib
elironrasib
Non-Small Cell Lung Cancer
$RVMD
Revolution Medicines, Inc.
Phase 2
elisrasib
elisrasib [INN]
Solid Tumor
D3 Bio Inc
Marketed
elivaldogene autotemcel
Skysona (elivaldogene autotemcel [INN])
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
Genetix Biotherapeutics Inc
Marketed
elosulfase alfa
Vimizim (elosulfase alfa)
Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome )
$BMRN
BIOMARIN PHARMACEUTICAL INC
Marketed
elotuzumab
Empliciti (elotuzumab)
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
